42 of 50
BACKNEXT
Scientist Runner-up: Leonard Bell
CEO, Alexion

In 1992, Bell left a teaching job at Yale to start biotech company Alexion. Fifteen years and $800 million later, he emerged with Soliris, the first FDA-approved drug of its kind that blocks `terminal complement,' a naturally occurring part of the immune system that plays a role in the life-threatening blood disease called PNH. Patients suffering from PNH and treated with Soliris experience its beneficial effects within days. Now Bell and Alexion are focusing on the potential benefits of Soliris on patients with other rare diseases for which there are no treatments, as well as kidney transplant patients who face a particularly high risk of organ rejection. --J.P.M.

NEXT: Scientist runner-up: Kylie Catchpole
Last updated July 09 2010: 1:19 PM ET
More Galleries
50 years of the Ford Mustang Take a drive down memory lane with our favorite photos of the car through the years. More
8 CEOs who took a pay cut in 2013 Median CEO pay inched up 9% in 2013 to $13.9 million. But not everyone got a bump last year. Here are eight CEOs who missed out. More
10 best convertibles now that spring has sprung It's finally time to put the top down. Here are our 10 favorite rides for the warmer months to come. More
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.